Raymond James Reiterates Buy Rating on MNR

Raymond James has reiterated its buy rating on MNR, setting a price target of $18. The announcement came on June 18, 2026, as analyst John Freeman maintained his positive outlook on the stock.

Other Institutional Activity in MNR

Several institutional investors have recently adjusted their positions in MNR. Kayne Anderson Capital Advisors LP reduced its holdings by 227,547 shares, leaving it with 18,960,034 shares valued at approximately $265.4 million. Similarly, American Century Companies Inc trimmed its stake by 188,160 shares, now holding 2,359,750 shares worth about $33.0 million. Meanwhile, Morgan Stanley increased its position by 114,933 shares, bringing its total to 1,182,328 shares valued at $16.6 million. Goldman Sachs Group Inc significantly reduced its stake by 877,376 shares, leaving it with 1,047,130 shares valued at $14.7 million.

MNR Stock Snapshot

MNR's shares are currently trading around $12.45. Although specific financial metrics such as market cap and P/E ratio were not provided, this price point reflects recent market activity and analyst predictions.

Insider Buying and Selling at Mach Natural Resources LP

Recent insider activity at MNR includes several transactions. IKAV General Partner S.A R.L. sold 1,422,476 shares on May 15, 2026, at an average price of $14.06. Tom Ward, CEO of the general partner of MNR, purchased 153,256 shares on April 13, 2026, at $13.05 each. Earlier, on April 8, 2026, IKAV sold 5,557,679 shares at $12.81, and Kayne Anderson Capital Advisors LP offloaded 3,442,321 shares at the same price. William Wallace McMullen made two purchases in March, acquiring 3,215 shares at $13.63 and 2,500 shares at $14.00.

Analysts Set New Price Targets

On June 18, 2026, Raymond James maintained its buy rating on MNR with an $18 price target. Earlier in the year, Truist Securities initiated coverage with a hold rating and a $14 target on March 24, 2026. Stifel maintained its buy rating with an $18 target on January 6, 2026. The broader analyst consensus remains positive, with a focus on potential growth.

About MNR

MNR operates within the [sector/industry] and is known for [describe main business activities briefly]. The company is headquartered in [location] and is led by CEO [name]. With a workforce of [number] employees, MNR continues to [describe any notable business focus or strategy].

Bottom Line

Raymond James' reiteration of a buy rating on MNR with an $18 target reflects continued confidence in the stock's potential. Institutional and insider activities show varied strategies, indicating diverse market perspectives. As always, it's important for investors to consider that these analyst ratings and institutional holdings are backward-looking and may not reflect current positions.